Klinikum Osnabrück GmbH

Osnabrück 49076

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Relapsing-Remitting, Secondary Prevention, Stroke

Studies at this site

• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed
• Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis — Completed